Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aleksandra M Michalowska

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Journal of Mammary Gland Biology and Neoplasia|February 20, 2004
Statistical issues in the design and analysis of gene expression microarray studies of animal modelsLisa M McShane, Joanna H Shih, Aleksandra M Michalowska
Breast Disease|December 7, 2007
Comparing genetically engineered mouse mammary cancer models with human breast cancer by expression profilingAlexander N Shoushtari, Aleksandra M Michalowska, Jeffrey E Green
Bioinformatics (Oxford, England)|July 13, 2004
Effects of pooling mRNA in microarray class comparisonsJoanna H Shih, Aleksandra M Michalowska, Kevin Dobbin, et al.
Molecular Endocrinology (Baltimore, Md.)|September 11, 2004
Gene expression profiling identifies a unique androgen-mediated inflammatory/immune signature and a PTEN (phosphatase and tensin homolog deleted on chromosome 10)-mediated apoptotic response specific to the rat ventral prostateKartiki V Desai, Aleksandra M Michalowska, Paturu Kondaiah, et al.
Cancer Research|July 20, 2006
Chemokine (C-C motif) ligand 2 mediates the prometastatic effect of dysadherin in human breast cancer cellsJeong-Seok Nam, Mi-Jin Kang, Adam M Suchar, et al.
Cancer Research|June 19, 2008
Identification of tumor-initiating cells in a p53-null mouse model of breast cancerMei Zhang, Fariba Behbod, Rachel L Atkinson, et al.
Cancer Research|June 17, 2006
Bone sialoprotein mediates the tumor cell-targeted prometastatic activity of transforming growth factor beta in a mouse model of breast cancerJeong-Seok Nam, Adam M Suchar, Mi-Jin Kang, et al.
Cancer Research|September 19, 2007
Transforming growth factor-beta can suppress tumorigenesis through effects on the putative cancer stem or early progenitor cell and committed progeny in a breast cancer xenograft modelBinwu Tang, Naomi Yoo, Mary Vu, et al.
Cancer Research|September 7, 2007
Identification of an integrated SV40 T/t-antigen cancer signature in aggressive human breast, prostate, and lung carcinomas with poor prognosisKristin K Deeb, Aleksandra M Michalowska, Cheol-Yong Yoon, et al.
SLAS Discovery : Advancing Life Sciences R & D|April 30, 2023
High-throughput approaches to uncover synergistic drug combinations in leukemiaEmma J Chory, Meng Wang, Michele Ceribelli, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of Mammary Gland Biology and Neoplasia|February 20, 2004
Statistical issues in the design and analysis of gene expression microarray studies of animal modelsLisa M McShane, Joanna H Shih, Aleksandra M Michalowska
Breast Disease|December 7, 2007
Comparing genetically engineered mouse mammary cancer models with human breast cancer by expression profilingAlexander N Shoushtari, Aleksandra M Michalowska, Jeffrey E Green
Bioinformatics (Oxford, England)|July 13, 2004
Effects of pooling mRNA in microarray class comparisonsJoanna H Shih, Aleksandra M Michalowska, Kevin Dobbin, et al.
Molecular Endocrinology (Baltimore, Md.)|September 11, 2004
Gene expression profiling identifies a unique androgen-mediated inflammatory/immune signature and a PTEN (phosphatase and tensin homolog deleted on chromosome 10)-mediated apoptotic response specific to the rat ventral prostateKartiki V Desai, Aleksandra M Michalowska, Paturu Kondaiah, et al.
Cancer Research|July 20, 2006
Chemokine (C-C motif) ligand 2 mediates the prometastatic effect of dysadherin in human breast cancer cellsJeong-Seok Nam, Mi-Jin Kang, Adam M Suchar, et al.
Cancer Research|June 19, 2008
Identification of tumor-initiating cells in a p53-null mouse model of breast cancerMei Zhang, Fariba Behbod, Rachel L Atkinson, et al.
Cancer Research|June 17, 2006
Bone sialoprotein mediates the tumor cell-targeted prometastatic activity of transforming growth factor beta in a mouse model of breast cancerJeong-Seok Nam, Adam M Suchar, Mi-Jin Kang, et al.
Cancer Research|September 19, 2007
Transforming growth factor-beta can suppress tumorigenesis through effects on the putative cancer stem or early progenitor cell and committed progeny in a breast cancer xenograft modelBinwu Tang, Naomi Yoo, Mary Vu, et al.
Cancer Research|September 7, 2007
Identification of an integrated SV40 T/t-antigen cancer signature in aggressive human breast, prostate, and lung carcinomas with poor prognosisKristin K Deeb, Aleksandra M Michalowska, Cheol-Yong Yoon, et al.
SLAS Discovery : Advancing Life Sciences R & D|April 30, 2023
High-throughput approaches to uncover synergistic drug combinations in leukemiaEmma J Chory, Meng Wang, Michele Ceribelli, et al.
Pageof 1